|
|
|
Insider
Information: |
Moulder Leon O Jr |
Relationship: |
|
City: |
Bloomington |
State: |
MN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
140,518 |
|
Indirect Shares
|
1,536,745 |
|
|
Direct
Value |
$775,867 |
|
|
Indirect Value
|
$1,060,147 |
|
|
Total
Shares |
1,677,263 |
|
|
Total
Value |
$1,836,014 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
MGI Pharma Inc |
MOGN |
President & CEO, Direc... |
2008-01-28 |
0 |
2008-01-23 |
0 |
Premium* |
|
New Abraxis Inc |
ABII |
President & CEO, Direc... |
2009-04-29 |
50,000 |
2009-04-29 |
0 |
Premium* |
|
Tesaro, Inc. |
TSRO |
Chief Executive Office... |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
Trevena Inc |
TRVN |
Director |
2019-02-01 |
50,000 |
2019-02-01 |
100,000 |
Premium* |
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
40,518 |
2021-01-15 |
0 |
Premium* |
|
Dianthus Therapeutics Ord Shs |
DNTH |
|
|
0 |
2024-01-22 |
1,436,745 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNTH |
Dianthus Therapeutics Ord... |
|
|
2024-01-22 |
4 |
A |
$12.00 |
$2,000,004 |
I/I |
166,667 |
1,436,745 |
0 |
- |
|
DNTH |
Dianthus Therapeutics Ord... |
Director |
|
2023-09-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,270,078 |
|
- |
|
ZLAB |
Zai Lab Ltd |
|
|
2023-06-29 |
4 |
A |
$26.45 |
$499,984 |
D/D |
18,903 |
40,518 |
0 |
- |
|
ZLAB |
Zai Lab Ltd |
Director |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,763 |
21,615 |
0 |
- |
|
ZLAB |
Zai Lab Ltd |
Director |
|
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,852 |
13,852 |
0 |
- |
|
TRVN |
Trevena Inc |
Director |
|
2019-02-01 |
4 |
B |
$1.02 |
$102,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2019-01-22 |
4 |
D |
$75.00 |
$375,000 |
I/I |
(5,000) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2019-01-22 |
4 |
D |
$75.00 |
$77,599,800 |
D/D |
(1,034,664) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2018-03-02 |
4 |
B |
$56.86 |
$284,640 |
I/I |
5,000 |
5,000 |
2.66 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,836 |
1,034,664 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
1,018,828 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2016-06-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
1,006,328 |
0 |
- |
|
TRVN |
Trevena Inc |
Director |
|
2014-12-10 |
4 |
B |
$4.06 |
$80,388 |
D/D |
19,800 |
50,000 |
2.39 |
- |
|
TRVN |
Trevena Inc |
Director |
|
2014-12-09 |
4 |
B |
$3.96 |
$119,592 |
D/D |
30,200 |
30,200 |
2.39 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2012-08-30 |
4 |
B |
$11.69 |
$116,900 |
D/D |
10,000 |
1,006,428 |
2.81 |
- |
|
TSRO |
Tesaro, Inc. |
Chief Executive Officer |
|
2012-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
428,571 |
996,428 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
CHIEF EXECUTIVE OFFICEROfficer |
|
2012-06-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
567,857 |
|
- |
|
ABII |
New Abraxis Inc |
President & CEO |
|
2009-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2008-01-28 |
4 |
D |
$41.00 |
$1,988,500 |
D/D |
(48,500) |
0 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2008-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
48,500 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2008-01-23 |
4 |
D |
$41.00 |
$7,824,358 |
D/D |
(190,838) |
17,500 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2008-01-23 |
4 |
D |
$41.00 |
$406,105 |
I/I |
(9,905) |
0 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2007-08-31 |
4/A |
D |
$23.57 |
$38,537 |
D/D |
(1,635) |
208,338 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2007-08-31 |
4 |
D |
$23.57 |
$38,537 |
D/D |
(1,635) |
207,638 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
President & CEO |
|
2007-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
209,273 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|